Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 5821-5830 of 10980

Edit search filters
  1. Clinical Evaluation of the CADence Device in Detection of Coronary Artery Diseases

    Rochester, MN

  2. A Study of Microvasculature Imaging of Breast Masses

    Rochester, MN

  3. The Relationship between Star Excursion Balance Test Performance and Hip Strength, Self- Report Outcomes and Core Stability in Patients 12 Weeks Status Post Hip Arthroscopy

    Minneapolis, MN

  4. Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma

  5. Safety Study of SEA-CD40 in Cancer Patients

    Rochester, MN

  6. Decision Aid for Shared Decision Making in Acute Respiratory Failure

    Rochester, MN

  7. Shared Decision Making in Patients with Neck and Back Pain – Options in Neck and Back Pain Management

    Rochester, MN

  8. Mavacamten in Hypertrophic Cardiomyopathy Patients Referred for Septal Reduction Therapy

    Rochester, MN

  9. A Study to Evaluate HH2853 in Patients with Relapsed/Refractory Non-Hodgkin's Lymphomas or Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Rochester, MN, Jacksonville, FL

  10. A Study to Evaluate Binimetinib in Combination with Encorafenib in Patients with Pancreatic Malignancies and a Somatic BRAFV600E Mutation

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer